Source: Annual Congress 2010 - Clinical issues in idiopathic pulmonary fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Hajiro, M. Ebina, M. Suga, Y. Inoue, H. Taniguchi, T. Nukiwa, Y. Taguchi, DLD Research Group in Japan (Nara, Miyagi, Kumamoto, Osaka, Aichi, Japan). Retrospective study on the treatment and prognosis of acute exacerbation of idiopathic pulmonary fibrosis in Japan. Eur Respir J 2010; 36: Suppl. 54, 3630

Member's Comments

No comment yet.

Related content which might interest you: Comparative survival analysis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis: Retrospective cohort study. Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers Year: 2018 Retrospective analysis of acute exacerbation in idiopathic interstitial pneumonias Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009 Diagnosis and therapy of acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF) in Germany Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018 Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study Source: Eur Respir J 2012; 40: 101-109 Year: 2012 Risk factors of acute exacerbation of idiopathic pulmonary fibrosis-extended analysis of the pirfenidone trial in Japan Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 Clinical predictors and explant lung pathology of acute exacerbation of idiopathic pulmonary fibrosis Source: ERJ Open Res, 6 (4) 00261-2019; 10.1183/23120541.00261-2019 Year: 2020 Clinical course and outcomes of acute exacerbation of fibrosing interstitial lung disease Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Retrospective analysis of characteristics and costs of hospital treatment of chronic obstructive pulmonary disease exacerbations Source: Eur Respir J 2006; 28: Suppl. 50, 624s Year: 2006 Impact of steroid therapy on exacerbation of chronic obstructive pulmonary disease with community-onset pneumonia: a multicenter retrospective cohort study Source: Virtual Congress 2020 – Prognosis and integrated management of COPD Year: 2020 Clinical experience with Nintedanib for treatment of idiopathic pulmonary fibrosis (IPF) in Spain. Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside Year: 2017 PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients Source: International Congress 2016 – IPF clinical Year: 2016 Prospective study of infectious bacterial etiology of acute exacerbation of chronic obstructive pulmonary disease in India Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Comparison of two physiotherapy treatments in patients with acute exacerbation of chronic obstructive pulmonary disease: a pilot study Source: Virtual Congress 2021 – A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases Year: 2021 Predictors of response to pirfenidone treatment in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2016 – IPF treatment II Year: 2016 Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD exacerbation Year: 2012 Clinical experience with nintedanib for the treatment of IPF in 80 cases Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Onset of symptoms in idiopathic pulmonary fibrosis: A case-control study Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 A large cohort study of clinical outcomes and prognostic predictors in patients with acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2014 – IPF and surroundings Year: 2014 Prognostic factors analysis of patients with acute exacerbation of idiopathic interstitial pneumonias treated by polymyxin B hemoperfusion Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Initial clinical experience with nintedanib for treatment of idiopathic pulmonary fibrosis (IPF): About 20 cases Source: International Congress 2015 – IPF: from bench to bedside Year: 2015